• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US MBT CEM KEEL TIB TRAY SZ1.5; MBT TIBIAL TRAY : KNEE TIBIAL TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US MBT CEM KEEL TIB TRAY SZ1.5; MBT TIBIAL TRAY : KNEE TIBIAL TRAY Back to Search Results
Catalog Number 129433115
Medical Device Problem Code Migration (4003)
Health Effect - Clinical Codes Bone Fracture(s) (1870); Pain (1994); Ambulation or Postural Difficulties (2544); Joint Laxity (4526); Unspecified Musculoskeletal problem (4535)
Date of Event 01/21/2021
Type of Reportable Event Serious Injury
Event or Problem Description
The litigation complaint received ad 12 mar 2024 was reviewed by the clinician.On (b)(6) 2014, the patient had a bilateral cemented total knee arthroplasty to address, bilateral knee pain and bilateral knee osteoarthritis end-stage.All components implanted were depuy products, including the cement and patella.On (b)(6) 2021, the patient was revised due to left total knee arthroplasty, to address the gross failure of the tibial tray with a well fixed femoral and patella component.Prior to surgery, the patient experienced pain, instability, and difficulty ambulating.During the procedure, the surgeon observed that the tibial tray was grossly loose and had collapsed causing significant bone loss on the anterior and lateral aspect of the tibia.During the procedure, the surgeon reported that during impaction a bone fracture along the lateral tibial cortex was noted.The tibial tray, insert, and femoral component were revised.Doi: (b)(6) 2014.Dor: (b)(6) 2021.Left knee.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).E3 initial reporter occupation: lawyer.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.The product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A records evaluation (mre) was not perform as part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot : the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MBT CEM KEEL TIB TRAY SZ1.5
Common Device Name
MBT TIBIAL TRAY : KNEE TIBIAL TRAY
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
JTE WARSAW MFG SITE
700 orthopaedic drive
warsaw IN
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key18992358
Report Number1818910-2024-06980
Device Sequence Number15338249
Product Code NJL
UDI-Device Identifier10603295025757
UDI-Public10603295025757
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/31/2018
Device Catalogue Number129433115
Device Lot Number6592817
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/12/2024
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date03/28/2024
Supplement Report FDA Received Date04/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/27/2013
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PFC SIGMARP STB TB IN 1.5 10.0; PFC*SIGMA/OV DOME PAT 3 PEG,32; SIGMA PS CEM FEM SZ1.5 L; SMARTSET MV 40G - EO; SMARTSET MV 40G - EO; SMARTSET MV 40G - EO
Outcome Attributed to Adverse Event Required Intervention;
Patient Age70 YR
Patient SexFemale
-
-